The Latest Cardiac and Vascular News
Abbott’s CentriMag™ Blood Pump, previously cleared for use up to six hours, now can be used to provide longer-term life support to critically ill patients, providing doctors more time to make critical care decisions Abbott’s CentriMag™ Pre-connected Pack, which combines a blood pump and oxygenator to form a life support […]
Collaboration honored for streamlining cardiovascular prior authorizations and assisting providers with evidence-based care paths BOSTON, April 25, 2023 /PRNewswire/ — Cohere Health, a recognized leader in transformative prior authorization (PA), has been named a winner of the KLAS 2023 Points of Light award for its collaboration with Humana Inc. and Karing Hearts […]
New technology enables ‘patches’ of 3D printed tissue to be applied onto the surface of damaged hearts as a safer and more cost-effective alternative to heart transplants. SYDNEY, April 20, 2023 /PRNewswire/ — Researchers from The University of Technology Sydney (UTS) have demonstrated that 3D bioprinted heart tissues can safely and effectively […]
PRINCETON, N.J., April 20, 2023 (GLOBE NEWSWIRE) — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announces that its pivotal STAR-T (Safe and Timely Antithrombotic Removal – Ticagrelor) randomized, controlled trial has enrolled 80 patients, […]
The HeartPlace partnership represents USHV’s 6th in Texas and 1st in Dallas-Fort Worth. NASHVILLE, Tenn.–(BUSINESS WIRE)–US Heart & Vascular (“USHV”), a leading national provider of support services to cardiovascular physician practices, has partnered with HeartPlace (“HeartPlace”), the largest physician-owned cardiology practice in Texas, focused on all aspects of cardiovascular care. “We […]
In a study assessing high-risk heart donors at the 43rd ISHLT Annual Meeting & Scientific Sessions, GUARDIAN-Heart Registry data indicates a significant reduction in Primary Graft Dysfunction (PGD), a severe post-transplant complication, potentially allowing for an increase in donor hearts available for heart transplant patients. CAMBRIDGE, MASSACHUSETTS, April 20, 2023 […]
Use of artificial intelligence technology efficiently identifies eligible patient candidates for pivotal clinical trial; program launched at The Christ Health Network SANTA CLARA, Calif. & ALISO VIEJO, Calif.–(BUSINESS WIRE)–Ancora Heart, Inc., a medical device company developing a novel transcatheter device-based therapy to address heart failure (HF), and egnite, Inc., a leading digital health […]
– Performance-Based Agreement Provides for Currax’s 72 Sales Representatives to Detail Esperion’s Products – – Reinforces Esperion’s Focus on Driving Persistent Growth By More Than Doubling Sales Team – ANN ARBOR, Mich., April 19, 2023 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today announced an agreement with Currax Pharmaceuticals LLC that provides for all of […]
Non-invasive, AI-enabled product helps CT readers to accurately*, efficiently, and consistently identify narrowings in the coronary arteries, advancing the HeartFlow portfolio MOUNTAIN VIEW, Calif., April 17, 2023 (GLOBE NEWSWIRE) — HeartFlow, Inc. today announced the launch of the RoadMap analysis, a new AI-enabled product that assists CT readers to accurately*, […]
Hoag is one of the first three sites in the nation enrolling patients in a post-market study Hoag cardiac surgeons are among an elite class of specialists experienced with this latest generation valve option Study expected to grow to include centers around the world NEWPORT BEACH, Calif., April 17, 2023 /PRNewswire/ — […]
